The molecular and cellular basis for oncogene collaboration in acute myeloid leukaemia
<p>Acute myeloid leukaemia (AML) is an aggressive malignancy of the bone marrow caused by the uncontrollable proliferation of immature myeloid cells that fail to terminally differentiate. Mutations in AML are acquired hierarchically, where pre-leukaemic mutations are acquired within haematopoi...
Main Author: | Di Genua, C |
---|---|
Other Authors: | Nerlov, C |
Format: | Thesis |
Published: |
2018
|
Subjects: |
Similar Items
-
The role of developmental stage specific programmes in infant acute lymphoblastic leukaemia
by: Ling, R
Published: (2024) -
H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
by: Godfrey, L, et al.
Published: (2020) -
Human fetal B-lymphopoiesis and acute lymphoblastic leukaemia: the impact of trisomy 21
by: O'Byrne, S
Published: (2019) -
Mechanisms of disease transformation in myeloproliferative neoplasms
by: O'Sullivan, J
Published: (2022) -
Cytogenetic profile of acute myeloid leukaemia (AML) patients in Singapore General Hospital (SGH)
by: Ho, Charmaine Jia Yi
Published: (2024)